"2"^^ . "54-55" . "3"^^ . "The impact of the cannabinoid CB2 receptor agonist JWH 015 on development of methamphetamine sensitization to locomotor/exploratory activity in mice"@en . "8" . . . "RIV/00216224:14110/04:00009924!RIV08-MSM-14110___" . . "567399" . "[172F293DEF7D]" . . "Psychiatrie" . . . "3"^^ . "Vliv agonsity kanabinoidn\u00EDch CB2 receptor\u016F, l\u00E1tky JWH 015, na rozvoj sensitizace k metamfetaminov\u00E9mu \u00FA\u010Dinku na lokomo\u010Dn\u011B-p\u00E1trac\u00ED chov\u00E1n\u00ED my\u0161\u00ED"@cs . . "Z(MSM 141100001)" . "The impact of the cannabinoid CB2 receptor agonist JWH 015 on development of methamphetamine sensitization to locomotor/exploratory activity in mice"@en . "14110" . . "RIV/00216224:14110/04:00009924" . "1211-7579" . . "behavioural sensitization; methamphetamine; JWH-015; locomotor activity; mice"@en . . . . . "The present study was designed to test a possible effect of selective agonist at cannabinoid CB2 receptor - JWH 015 (JWH) on behavioural sensitization to MET. Behavioural changes were measured in the open field test. MET and combined MET+JWH pretreatments were administered for 7 days to the mice at the doses of 2.5 mg/kg/day and 5 mg/kg/ day, respectively. On the day 8 all mice were given a "challenge dose" of MET 2.5 mg/kg to check a development of sensitization phenomenon. The sensitization to MET has not been altered in the case of use of JWH in the pretreatment." . "Landa, Leo\u0161" . "Suppl. 1" . . . "\u0160ulcov\u00E1, Alexandra" . "The impact of the cannabinoid CB2 receptor agonist JWH 015 on development of methamphetamine sensitization to locomotor/exploratory activity in mice" . "\u0160lais, Karel" . "Vliv agonsity kanabinoidn\u00EDch CB2 receptor\u016F, l\u00E1tky JWH 015, na rozvoj sensitizace k metamfetaminov\u00E9mu \u00FA\u010Dinku na lokomo\u010Dn\u011B-p\u00E1trac\u00ED chov\u00E1n\u00ED my\u0161\u00ED"@cs . "The present study was designed to test a possible effect of selective agonist at cannabinoid CB2 receptor - JWH 015 (JWH) on behavioural sensitization to MET. Behavioural changes were measured in the open field test. MET and combined MET+JWH pretreatments were administered for 7 days to the mice at the doses of 2.5 mg/kg/day and 5 mg/kg/ day, respectively. On the day 8 all mice were given a "challenge dose" of MET 2.5 mg/kg to check a development of sensitization phenomenon. The sensitization to MET has not been altered in the case of use of JWH in the pretreatment."@en . "CZ - \u010Cesk\u00E1 republika" . "Agonista kanabinoidn\u00EDch CB2 receptor\u016F JWH 015 nep\u016Fsob\u00ED zk\u0159\u00ED\u017Eenou sensitizai k \u00FA\u010Dink\u016Fm metamfetaminu na lkomo\u010Dn\u011B-p\u00E1trac\u00ED chov\u00E1n\u00ED my\u0161\u00ED."@cs . . . . . "The impact of the cannabinoid CB2 receptor agonist JWH 015 on development of methamphetamine sensitization to locomotor/exploratory activity in mice" .